Author:
Pons Benavent M.,Silva Díaz E.,Guillén Climent S.,Monteagudo Castro C.
Subject
Dermatology,Histology,Pathology and Forensic Medicine
Reference10 articles.
1. Skin problems and EGFR-tyrosine kinase inhibitor;Kokuki;Jpn J Clin Oncol.,2016
2. Votrient®. Ficha técnica del medicamento. Centro de información online de medicamentos de la Agencia Europea del Medicamento (EMA) [consultado 3 Abr 2019]. Disponible en: http://www.ema.europa.eu
3. Reacciones capilares de las nuevas terapias dirigidas contra el cáncer;Mir-Bonafé;Actas Dermosifiliogr.,2019
4. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib;Lee;Br J Dermatol.,2009
5. Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib;Zuo;JAMA Dermatol,2015